<DOC>
	<DOCNO>NCT02243319</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetic drug interaction HGP1201 HGP0904</brief_summary>
	<brief_title>Investigating Pharmacokinetic Drug Interactions Between HGP1201 HGP0904</brief_title>
	<detailed_description>Randomized , open-label , multiple dose , 3-treatment , 6-sequence , 3-period , crossover study , The purpose study investigate pharmacokinetic drug interaction HGP1201 HGP0904</detailed_description>
	<criteria>Healthy male volunteer , age 19~45 year The result Body Mass Index ( BMI ) less 19 kg/m2 , 28 kg/m2 Subject ability comprehend study objective , content property study drug participate trial . Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study History relevant drug allergy clinically significant hypersensitivity reaction .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>